2026-2030年全球先進治療CoC軟體市場

全球先進治療CoC軟體市場預計將從2025年到2030年成長至127,735,000美元，預測期間內複合年成長率為18.1%。

本報告對全球先進治療CoC軟體市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約25家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場成長的因素包括：細胞和基因療法產品線商業化進程的加速、全球監管合規和品質保證要求的日益嚴格，以及區塊鏈和人工智慧等技術的應用提升了市場透明度。

本次調查客觀地結合了一手和二手訊息，包括來自主要行業相關人員的信息。本報告包含對主要公司的分析、全面的市場規模數據、細分市場數據及區域分析，以及供應商格局數據。此外，報告還包含歷史數據和預測數據。

本研究指出，供應鏈編配中預測分析和人工智慧的日益普及將是未來幾年全球先進治療藥物供應鏈管理（CoC）軟體市場成長的關鍵促進因素。此外，向雲端原生架構和可互通的SaaS解決方案的轉變，以及為支援照護現場和分散式生產模式而增強的數位追蹤能力，預計也將產生巨大的市場需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球先進治療CoC軟體市場
• 基於組件的細分市場分析，2020-2024 年
• 2020-2024 年最終用戶細分市場分析
• 按類型分類的細分市場分析，2020-2024 年
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球先進治療性CoC軟體市場
• 地緣政治衝突的影響：全球先進治療CoC軟體市場。

第7章：五力分析

第8章 市場區隔：按組件

• 比較：按組件
• 軟體
• 服務
• 市場機會：按組件分類

第9章 市場區隔：依最終用戶分類

• 比較：按最終用戶
• 細胞療法和基因療法製造商
• 醫院和治療中心
• 其他
• 市場機會：依最終用戶分類

第10章 市場區隔：依類型

• 比較：按類型
• CoC追蹤
• CoI 管理
• 監管合規性和審計追蹤
• 其他
• 市場機會：按類型分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 荷蘭
  • 義大利
  • 西班牙
  • 俄羅斯
• 亞洲
  • 中國
  • 日本
  • 韓國
  • 印度
  • 新加坡
  • 印尼
  • 泰國
• 世界其他地區（RoW）
  • 澳洲
  • UAE
  • 巴西
  • 南非
  • 沙烏地阿拉伯
  • 土耳其
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• Accenture Plc
• Bio-IT World
• CloudLIMS.com
• Cryoport Systems LLC
• Dassault Systemes SE
• IDBS Ltd
• Korber Pharma GmbH
• MasterControl Solutions Inc.
• Persistent Systems Ltd.
• Rockwell Automation Inc.
• Salesforce Inc.
• SAP SE
• Siemens AG
• TraceLink Inc.
• TrakCel

第16章附錄

The global advanced therapy chain-of-custody software market is forecasted to grow by USD 127735.0 thousand during 2025-2030, accelerating at a CAGR of 18.1% during the forecast period. The report on the global advanced therapy chain-of-custody software market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalation in commercialization of cell and gene therapy pipelines, stringent global regulatory compliance and quality assurance requirements, technological integration of blockchain and ai for enhanced transparency.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global advanced therapy chain-of-custody software market is segmented as below:

By Component

• Software
• Services

By End-User

• Cell and gene therapy manufacturers
• Hospitals and treatment centers
• Others

By Type

• Chain-of-custody tracking
• Chain-of-identity management
• Regulatory compliance and audit trail
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • The Netherlands
  • Italy
  • Spain
  • Russia
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the proliferation of predictive analytics and ai in supply chain orchestration as one of the prime reasons driving the global advanced therapy chain-of-custody software market growth during the next few years. Also, transition toward cloud-native architectures and interoperable saas solutions and expansion of digital tracking capabilities to support point-of-care and decentralized manufacturing models will lead to sizable demand in the market.

The report on the global advanced therapy chain-of-custody software market covers the following areas:

• Global advanced therapy chain-of-custody software market sizing
• Global advanced therapy chain-of-custody software market forecast
• Global advanced therapy chain-of-custody software market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global advanced therapy chain-of-custody software market vendors that include Accenture Plc, Autolomous Ltd, Bio-IT World, Clarkston Consulting, CloudLIMS.com, Cryoport Systems LLC, Dassault Systemes SE, IDBS Ltd, Korber Pharma GmbH, MasterControl Solutions Inc., NMDP BioTherapies, Persistent Systems Ltd., Rockwell Automation Inc., Salesforce Inc., SAP SE, Siemens AG, Tenthpin Management Consultant, Title21 Health Solutions, TraceLink Inc., TrakCel. Also, the global advanced therapy chain-of-custody software market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Component
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Advanced Therapy Chain-Of-Custody Software Market 2020 - 2024
  • Historic Market Size - Data Table on Global Advanced Therapy Chain-Of-Custody Software Market 2020 - 2024 ($ thousand)
• 5.2 Component segment analysis 2020 - 2024
  • Historic Market Size - Component Segment 2020 - 2024 ($ thousand)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ thousand)
• 5.4 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ thousand)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ thousand)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Advanced Therapy Chain-of-Custody Software Market
• 6.2 Impact of geopolitical conflicts on Global Advanced Therapy Chain-of-Custody Software Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Component

• 8.1 Market segments
• 8.2 Comparison by Component
• 8.3 Software - Market size and forecast 2025-2030
• 8.4 Services - Market size and forecast 2025-2030
• 8.5 Market opportunity by Component
  • Market opportunity by Component ($ thousand)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Cell and gene therapy manufacturers - Market size and forecast 2025-2030
• 9.4 Hospitals and treatment centers - Market size and forecast 2025-2030
• 9.5 Others - Market size and forecast 2025-2030
• 9.6 Market opportunity by End-user
  • Market opportunity by End-user ($ thousand)

10 Market Segmentation by Type

• 10.1 Market segments
• 10.2 Comparison by Type
• 10.3 Chain-of-custody tracking - Market size and forecast 2025-2030
• 10.4 Chain-of-identity management - Market size and forecast 2025-2030
• 10.5 Regulatory compliance and audit trail - Market size and forecast 2025-2030
• 10.6 Others - Market size and forecast 2025-2030
• 10.7 Market opportunity by Type
  • Market opportunity by Type ($ thousand)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 The Netherlands - Market size and forecast 2025-2030
  • 12.4.5 Italy - Market size and forecast 2025-2030
  • 12.4.6 Spain - Market size and forecast 2025-2030
  • 12.4.7 Russia - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 South Korea - Market size and forecast 2025-2030
  • 12.5.4 India - Market size and forecast 2025-2030
  • 12.5.5 Singapore - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
  • 12.5.7 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Australia - Market size and forecast 2025-2030
  • 12.6.2 UAE - Market size and forecast 2025-2030
  • 12.6.3 Brazil - Market size and forecast 2025-2030
  • 12.6.4 South Africa - Market size and forecast 2025-2030
  • 12.6.5 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.6 Turkey - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ thousand)
  • Data Tables on Market opportunity by geography ($ thousand)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Escalation in commercialization of cell and gene therapy pipelines
  • Stringent global regulatory compliance and quality assurance requirements
  • Technological integration of blockchain and AI for enhanced transparency
• 13.2 Market challenges
  • Fragmentation of digital ecosystems and absence of global interoperability standards
  • Economic barriers and prohibitive costs of specialized system integration
  • Escalating cybersecurity threats and complexity of global data privacy compliance
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Proliferation of predictive analytics and AI in supply chain orchestration
  • Transition toward cloud-native architectures and interoperable SaaS solutions
  • Expansion of digital tracking capabilities to support point-of-care and decentralized manufacturing models

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Accenture Plc
  • Accenture Plc - Overview
  • Accenture Plc - Business segments
  • Accenture Plc - Key news
  • Accenture Plc - Key offerings
  • Accenture Plc - Segment focus
  • SWOT
• 15.5 Bio-IT World
  • Bio-IT World - Overview
  • Bio-IT World - Product / Service
  • Bio-IT World - Key offerings
  • SWOT
• 15.6 CloudLIMS.com
  • CloudLIMS.com - Overview
  • CloudLIMS.com - Product / Service
  • CloudLIMS.com - Key offerings
  • SWOT
• 15.7 Cryoport Systems LLC
  • Cryoport Systems LLC - Overview
  • Cryoport Systems LLC - Product / Service
  • Cryoport Systems LLC - Key offerings
  • SWOT
• 15.8 Dassault Systemes SE
  • Dassault Systemes SE - Overview
  • Dassault Systemes SE - Business segments
  • Dassault Systemes SE - Key news
  • Dassault Systemes SE - Key offerings
  • Dassault Systemes SE - Segment focus
  • SWOT
• 15.9 IDBS Ltd
  • IDBS Ltd - Overview
  • IDBS Ltd - Product / Service
  • IDBS Ltd - Key offerings
  • SWOT
• 15.10 Korber Pharma GmbH
  • Korber Pharma GmbH - Overview
  • Korber Pharma GmbH - Product / Service
  • Korber Pharma GmbH - Key offerings
  • SWOT
• 15.11 MasterControl Solutions Inc.
  • MasterControl Solutions Inc. - Overview
  • MasterControl Solutions Inc. - Product / Service
  • MasterControl Solutions Inc. - Key offerings
  • SWOT
• 15.12 Persistent Systems Ltd.
  • Persistent Systems Ltd. - Overview
  • Persistent Systems Ltd. - Product / Service
  • Persistent Systems Ltd. - Key offerings
  • SWOT
• 15.13 Rockwell Automation Inc.
  • Rockwell Automation Inc. - Overview
  • Rockwell Automation Inc. - Business segments
  • Rockwell Automation Inc. - Key news
  • Rockwell Automation Inc. - Key offerings
  • Rockwell Automation Inc. - Segment focus
  • SWOT
• 15.14 Salesforce Inc.
  • Salesforce Inc. - Overview
  • Salesforce Inc. - Business segments
  • Salesforce Inc. - Key news
  • Salesforce Inc. - Key offerings
  • Salesforce Inc. - Segment focus
  • SWOT
• 15.15 SAP SE
  • SAP SE - Overview
  • SAP SE - Business segments
  • SAP SE - Key news
  • SAP SE - Key offerings
  • SAP SE - Segment focus
  • SWOT
• 15.16 Siemens AG
  • Siemens AG - Overview
  • Siemens AG - Business segments
  • Siemens AG - Key news
  • Siemens AG - Key offerings
  • Siemens AG - Segment focus
  • SWOT
• 15.17 TraceLink Inc.
  • TraceLink Inc. - Overview
  • TraceLink Inc. - Product / Service
  • TraceLink Inc. - Key offerings
  • SWOT
• 15.18 TrakCel
  • TrakCel - Overview
  • TrakCel - Product / Service
  • TrakCel - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations